TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 45 filers reported holding TFF PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $296,409 | -26.1% | 846,884 | -0.8% | 0.00% | – |
| Q2 2023 | $401,221 | -31.9% | 853,663 | -0.7% | 0.00% | – |
| Q1 2023 | $588,980 | -34.7% | 859,449 | 0.0% | 0.00% | – |
| Q4 2022 | $902,422 | -74.4% | 859,449 | -1.0% | 0.00% | – |
| Q3 2022 | $3,526,000 | -28.1% | 868,431 | 0.0% | 0.00% | – |
| Q2 2022 | $4,907,000 | -10.1% | 868,431 | +0.4% | 0.00% | – |
| Q1 2022 | $5,458,000 | -24.2% | 864,983 | +6.5% | 0.00% | – |
| Q4 2021 | $7,203,000 | +17.4% | 812,170 | +2.2% | 0.00% | – |
| Q3 2021 | $6,138,000 | -17.2% | 795,038 | +3.0% | 0.00% | – |
| Q2 2021 | $7,417,000 | -21.6% | 771,854 | +10.8% | 0.00% | – |
| Q1 2021 | $9,457,000 | +5.4% | 696,907 | +11.2% | 0.00% | – |
| Q4 2020 | $8,975,000 | +47.5% | 626,770 | +90.2% | 0.00% | – |
| Q3 2020 | $6,086,000 | +1562.8% | 329,531 | +418.3% | 0.00% | – |
| Q2 2020 | $366,000 | +50.0% | 63,584 | 0.0% | 0.00% | – |
| Q1 2020 | $244,000 | -12.2% | 63,584 | +22.2% | 0.00% | – |
| Q4 2019 | $278,000 | – | 52,031 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 2,655,235 | $929,332 | 0.44% |
| Worth Venture Partners, LLC | 646,832 | $226,391 | 0.13% |
| CARLSON CAPITAL L P | 4,875,000 | $1,706,250 | 0.13% |
| GAGNON SECURITIES LLC | 162,565 | $56,897 | 0.01% |
| DRW Securities, LLC | 1,000,000 | $350 | 0.01% |
| Westside Investment Management, Inc. | 43,600 | $15,263 | 0.00% |
| THOMPSON DAVIS & CO., INC. | 10,000 | $3,500 | 0.00% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 22,066 | $8 | 0.00% |
| PRINCETON CAPITAL MANAGEMENT LLC | 18,161 | $6,356 | 0.00% |
| Quantum Private Wealth, LLC | 11,082 | $3,879 | 0.00% |